Otonomy vs Vaxart, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Otonomy and Vaxart, Inc. are worth about the same: $113 M and $117 M (market caps of Jan 7, 2022 for Otonomy and Oct 22, 2026 for Vaxart, Inc.). Otonomy's value is the last on file, from Jan 7, 2022: no market-data feed is connected for its exchange yet.
- Vaxart, Inc. had more revenue: $237 M in the year to December 2025 against $0 M for Otonomy in the year to December 2020.
- Vaxart, Inc. made a net profit of $16 M, while Otonomy made a net loss of $45 M.
- Vaxart, Inc. keeps more of each dollar of sales: a net margin of 6.9% against -16555.6% for Otonomy.
Market value, the same start = 100
From Jan 2022: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Otonomy OTIC | Vaxart, Inc. VXRT · #18,166 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | 2008 | 2004 |
| Size | ||
| Market cap | $113 M* | $117 M |
| Revenue | $0 M | $237 M |
| Net income | $-45 M | $16 M▲ best |
| Employees | — | 15 |
| Valuation | ||
| P/E ratio | — | 4.0× |
| Price to sales | — | 0.7× |
| Price to book | — | 1.3× |
| Free cash flow yield | — | 6.5% |
| Profitability | ||
| Operating margin | — | 7.6% |
| Net margin | — | 6.9% |
| Return on equity | — | 22.3% |
| Growth | ||
| Revenue growth | — | 726.7% |
| Cash | ||
| Free cash flow margin | — | 3.2% |
| Altman Z-score zone | — | distress |
| Data as of | Market cap Jan 2022 | Market cap Oct 2026; ratios FY2025 |
Questions and answers#
Which is bigger, Otonomy or Vaxart, Inc.?
Otonomy and Vaxart, Inc. are worth about the same: $113 M and $117 M (market caps of Jan 7, 2022 for Otonomy and Oct 22, 2026 for Vaxart, Inc.). Otonomy's value is the last on file, from Jan 7, 2022: no market-data feed is connected for its exchange yet.
Which makes more money, Otonomy or Vaxart, Inc.?
Vaxart, Inc. had more revenue: $237 M in the year to December 2025 against $0 M for Otonomy in the year to December 2020. Vaxart, Inc. made a net profit of $16 M, while Otonomy made a net loss of $45 M.
Which is more profitable, Otonomy or Vaxart, Inc.?
Vaxart, Inc. keeps more of each dollar of sales: a net margin of 6.9% against -16555.6% for Otonomy.